Abstract |
|
Authors | P H M de Mulder, J B A G Haanen, S Sleijfer, W H J Kruit, J A Gietema, D J Richel, G Groenewegen, E E Voest, A J M van den Eertwegh, S Osanto, R L H Jansen, P F A Mulders |
Journal | Nederlands tijdschrift voor geneeskunde
(Ned Tijdschr Geneeskd)
Vol. 152
Issue 7
Pg. 371-5
(Feb 16 2008)
ISSN: 0028-2162 [Print] Netherlands |
Vernacular Title | Angiogeneseremmers voor de systemische behandeling van gemetastaseerd niercelcarcinoom: sunitinib, sorafenib, bevacizumab en temsirolimus. |
PMID | 18380383
(Publication Type: Journal Article, Review, Comment)
|
Chemical References |
- Angiogenesis Inhibitors
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
- Benzenesulfonates
- Indoles
- Phenylurea Compounds
- Pyridines
- Pyrroles
- Niacinamide
- Bevacizumab
- temsirolimus
- Sorafenib
- Sunitinib
- Sirolimus
|
Topics |
- Angiogenesis Inhibitors
(therapeutic use)
- Antibodies, Monoclonal
(therapeutic use)
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
(therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
- Benzenesulfonates
(therapeutic use)
- Bevacizumab
- Carcinoma, Renal Cell
(drug therapy)
- Disease-Free Survival
- Humans
- Immunotherapy
- Indoles
(therapeutic use)
- Kidney Neoplasms
(drug therapy)
- Neoplasm Metastasis
- Niacinamide
(analogs & derivatives)
- Phenylurea Compounds
- Pyridines
(therapeutic use)
- Pyrroles
(therapeutic use)
- Signal Transduction
- Sirolimus
(analogs & derivatives, therapeutic use)
- Sorafenib
- Sunitinib
- Treatment Outcome
|